ILMN - Financial Reports List - Illumina, Inc. - IntrinsicAlpha

Illumina, Inc. ILMN

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 74.35

1.12 %

$ 11.8 B

Market Cap

-9.36

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-29	-1.60%	206.25%	407.02%
Annual Report	FY	10-K	2024-12-29	-2.93%	-5.34%	22.08%
Quarterly Report	Q3	8-K	2024-09-29	-3.49%	193.50%	198.28%
Quarterly Report	Q2	8-K	2024-06-30	-5.44%	-749.57%	650.00%
Quarterly Report	Q1	8-K	2024-03-31	-1.01%	-4200.00%	7.81%
Quarterly Report	Q4	8-K	2023-12-31	3.60%	-26.62%	55.12%
Annual Report	FY	10-K	2023-12-31	-1.75%	73.64%	74.42%
Quarterly Report	Q3	8-K	2023-10-01	0.36%	80.24%	79.38%
Quarterly Report	Q2	8-K	2023-07-02	1.20%	56.26%	84.80%
Quarterly Report	Q1	8-K	2023-04-02	-11.12%	-96.51%	-34.78%

1